{"blog": [], "keywords": [{"value": "Clinical Trials", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Cancer", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "3", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/05/15/magazine/exceptional-responders-cancer-the-lazarus-effect.html", "document_type": "article", "byline": {"person": [{"lastname": "COOK", "firstname": "Gareth", "role": "reported", "organization": "", "rank": 1}], "original": "By GARETH COOK", "contributor": ""}, "type_of_material": "News", "multimedia": [{"url": "images/2016/05/15/magazine/15responders1/15responders1-thumbWide-v2.jpg", "legacy": {"wide": "images/2016/05/15/magazine/15responders1/15responders1-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/05/15/magazine/15responders1/15responders1-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2016/05/15/magazine/15responders1/15responders1-articleLarge-v2.jpg", "xlargeheight": "700", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 700}, {"url": "images/2016/05/15/magazine/15responders1/15mag-15responders-t_CA0-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/15/magazine/15responders1/15mag-15responders-t_CA0-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Magazine", "word_count": "6120", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Most clinical trials for cancer drugs are failures. But for a handful of patients, a drug proves to be nearly a cure. What can science learn from these \u201cexceptional responders\u201d?", "pub_date": "2016-05-12T09:00:24Z", "news_desk": "Magazine", "headline": {"kicker": "The Health Issue", "print_headline": "The Lazarus Effect", "main": "Learning From the Lazarus Effect", "content_kicker": "The Health Issue"}, "print_page": "48", "snippet": "Most clinical trials for cancer drugs are failures. But for a handful of patients, a drug proves to be nearly a cure. What can science learn from these \u201cexceptional responders\u201d?", "_id": "5734462938f0d857ffcaea2c", "slideshow_credits": null, "abstract": "Some cancer patients respond exceptionally well to specific cancer treatments that fail to help others, phenomenon referred to as 'Lazarus effect;' known as exceptional responders, these patients have puzzled researchers, who are working to understand implications for cancer treatment."}